title: Proteolysis controls endogenous substance P levels.
abstract: Substance P (SP) is a prototypical neuropeptide with roles in pain and inflammation. Numerous mechanisms regulate endogenous SP levels, including the differential expression of SP mRNA and the controlled secretion of SP from neurons. Proteolysis has long been suspected to regulate extracellular SP concentrations but data in support of this hypothesis is scarce. Here, we provide evidence that proteolysis controls SP levels in the spinal cord. Using peptidomics to detect and quantify endogenous SP fragments, we identify the primary SP cleavage site as the C-terminal side of the ninth residue of SP. If blocking this pathway increases SP levels, then proteolysis controls SP concentration. We performed a targeted chemical screen using spinal cord lysates as a proxy for the endogenous metabolic environment and identified GM6001 (galardin, ilomastat) as a potent inhibitor of the SP(1-9)-producing activity present in the tissue. Administration of GM6001 to mice results in a greater-than-three-fold increase in the spinal cord levels of SP, which validates the hypothesis that proteolysis controls physiological SP levels.
authors.affiliation: Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, United States of America.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Mitchell
authors.forename: Anna Mari
authors.initials: AM
authors.lastname: Lone
authors.forename: Arthur D
authors.initials: AD
authors.lastname: Tinoco
authors.forename: Alan
authors.initials: A
authors.lastname: Saghatelian
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D013058:Mass Spectrometry; D045726:Metalloproteases / Q000037:antagonists & inhibitors / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D010446:Peptide Fragments / Q000737:chemistry / Q000378:metabolism; D059748:Proteolysis / Q000187:drug effects; D013116:Spinal Cord / Q000378:metabolism; D013373:Substance P / Q000737:chemistry / Q000378:metabolism*
chemical_list: D004791:Enzyme Inhibitors; D010446:Peptide Fragments; D013373:Substance P; D045726:Metalloproteases
references.citation: Brain Res. 1979 Jul 6;170(1):209-13
references.pmid: 466404
references.citation: Biochem Biophys Res Commun. 1984 Nov 30;125(1):244-50
references.pmid: 6210084
references.citation: Neuropsychobiology. 2002;45 Suppl 1:2-6
references.pmid: 11893870
references.citation: Eur J Pharmacol. 1985 Sep 24;115(2-3):309-11
references.pmid: 2415371
references.citation: Proc Natl Acad Sci U S A. 2012 May 29;109(22):8523-7
references.pmid: 22586115
references.citation: J Biol Chem. 2001 Apr 20;276(16):13248-55
references.pmid: 11278902
references.citation: J Med Chem. 1982 Sep;25(9):1009-15
references.pmid: 6182294
references.citation: Behav Neural Biol. 1986 Mar;45(2):230-9
references.pmid: 2421708
references.citation: Chem Rev. 1999 Sep 8;99(9):2735-76
references.pmid: 11749499
references.citation: Biochemistry. 1992 Aug 11;31(31):7152-4
references.pmid: 1322694
references.citation: Biol Psychiatry. 1985 Sep;20(9):965-70
references.pmid: 2411304
references.citation: Biochem Biophys Res Commun. 1983 Oct 31;116(2):735-42
references.pmid: 6197070
references.citation: Eur J Biochem. 1981 Feb;114(2):315-27
references.pmid: 7011809
references.citation: Neuroscience. 1992 Aug;49(3):681-91
references.pmid: 1380137
references.citation: J Biol Chem. 1999 Feb 12;274(7):4053-8
references.pmid: 9933597
references.citation: Nature. 2007 Jan 11;445(7124):168-76
references.pmid: 17151600
references.citation: Regul Pept. 2001 Sep 15;101(1-3):43-9
references.pmid: 11495678
references.citation: Biochemistry. 2011 Mar 29;50(12):2213-22
references.pmid: 21299233
references.citation: FEBS Lett. 1978 Jul 15;91(2):360-4
references.pmid: 680144
references.citation: Peptides. 1993 Jan-Feb;14(1):85-95
references.pmid: 7680130
references.citation: Nat Rev Drug Discov. 2006 Sep;5(9):785-99
references.pmid: 16955069
references.citation: J Mol Biol. 2000 Feb 18;296(2):341-9
references.pmid: 10669592
references.citation: Nucleic Acids Res. 2011 Jan;39(Database issue):D670-6
references.pmid: 21062828
references.citation: Arthritis Rheum. 1992 Apr;35(4):369-75
references.pmid: 1373619
references.citation: Biochemistry. 2009 Apr 7;48(13):2868-77
references.pmid: 19196155
references.citation: Peptides. 1984 Jul-Aug;5(4):769-76
references.pmid: 6208535
references.citation: Nucleic Acids Res. 2012 Jan;40(Database issue):D343-50
references.pmid: 22086950
references.citation: Eur J Pharmacol. 2008 Feb 26;581(1-2):157-63
references.pmid: 18093581
references.citation: Mol Cell. 2000 Feb;5(2):207-16
references.pmid: 10882063
references.citation: Peptides. 1983 Sep-Oct;4(5):763-8
references.pmid: 6197702
references.citation: PLoS One. 2010 Sep 29;5(9):
references.pmid: 20927376
references.citation: Peptides. 1983 Jan-Feb;4(1):31-5
references.pmid: 6191314
references.citation: J Neurosci. 1995 Mar;15(3 Pt 1):2081-96
references.pmid: 7534343
references.citation: Proc Natl Acad Sci U S A. 1983 May;80(10):3111-5
references.pmid: 6190172
references.citation: Protein Sci. 1998 Mar;7(3):706-19
references.pmid: 9541403
references.citation: J Am Chem Soc. 2010 Mar 24;132(11):3819-30
references.pmid: 20178363
references.citation: Brain Res. 1996 Nov 11;739(1-2):70-8
references.pmid: 8955926
references.citation: Neurosci Lett. 2001 May 4;303(2):137-9
references.pmid: 11311511
references.citation: Eur J Pharmacol. 1993 Jul 6;238(1):111-5
references.pmid: 7691618
references.citation: Prep Biochem Biotechnol. 1997 Feb;27(1):59-78
references.pmid: 9090724
references.citation: J Neurochem. 2003 Oct;87(2):508-21
references.pmid: 14511128
references.citation: Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10000-5
references.pmid: 15220480
references.citation: J Cardiovasc Pharmacol. 1995;26 Suppl 3:S65-8
references.pmid: 8587470
references.citation: J Neurosci. 1991 Apr;11(4):1016-31
references.pmid: 1707092
references.citation: J Mol Recognit. 1998 Winter;11(1-6):266-9
references.pmid: 10076855
references.citation: Neuropharmacology. 1991 Nov;30(11):1219-23
references.pmid: 1723178
references.citation: Biochemistry. 2009 Dec 22;48(50):11971-81
references.pmid: 19911840
references.citation: J Exp Med. 1995 Jun 1;181(6):2271-5
references.pmid: 7760013
references.citation: Neuropeptides. 2000 Oct;34(5):256-71
references.pmid: 11049730
references.citation: Brain Res. 1980 Jun 23;192(2):477-86
references.pmid: 6155176
references.citation: Biochem Biophys Res Commun. 1979 Jul 27;89(2):474-8
references.pmid: 114175
references.citation: Peptides. 2002 Nov;23(11):2025-34
references.pmid: 12431741
references.citation: J Pharmacol Exp Ther. 1996 Nov;279(2):662-7
references.pmid: 8930169
references.citation: Physiol Rev. 1993 Apr;73(2):229-308
references.pmid: 7682720
references.citation: Braz J Med Biol Res. 1994 Aug;27(8):1865-76
references.pmid: 7538373
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6874-9
references.pmid: 10823914
references.citation: J Neurochem. 1980 Sep;35(3):527-35
references.pmid: 6161226
references.citation: J Cereb Blood Flow Metab. 2009 Jul;29(7):1284-92
references.pmid: 19417756
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2630-5
references.pmid: 9482938
references.citation: Neuropeptides. 1993 Aug;25(2):95-103
references.pmid: 7692345
references.citation: Biomed Chromatogr. 2006 Dec;20(12):1344-50
references.pmid: 16977591
references.citation: Brain Res. 1979 May 25;168(2):247-59
references.pmid: 221070
references.citation: Gastroenterology. 1988 Oct;95(4):952-7
references.pmid: 2457534
references.citation: J Chromatogr A. 2000 Sep 29;893(1):107-13
references.pmid: 11043591
references.citation: Mol Cell Proteomics. 2009 Oct;8(10):2339-49
references.pmid: 19596694